| Code | 5103E | ||||||||||
| MA number | 30/0269/23-S | ||||||||||
| Product Form: | tbl flm 14x20 mg (blis.PVC/PE/PVDC//Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | AS GRINDEKS, Latvia | ||||||||||
| Therapeutic Class: | 30 - ANTIDEPRESSIVA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.12.2023 |
| Validity: | 21.12.2028 |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Escitalopram Grindeks_12_2023.pdf
|
| SPC: |
SPC_Escitalopram Grindeks_12_2023.pdf
|
| Safety feature | Yes |
| Data update: | 27.12.2023 |
